O
Ondine Biomedical Inc
LSE:OBI
Ondine Biomedical Inc
LSE:OBI
Price:
10.25
GBX
Market Cap:
41.4m
GBX
Income Statement
Earnings Waterfall
Ondine Biomedical Inc
Ondine Biomedical Inc
|
Revenue
|
1.6m
CAD
|
|
Cost of Revenue
|
-653k
CAD
|
|
Gross Profit
|
981k
CAD
|
|
Operating Expenses
|
-15.6m
CAD
|
|
Operating Income
|
-14.6m
CAD
|
|
Other Expenses
|
331k
CAD
|
|
Net Income
|
-14.3m
CAD
|
Income Statement
Ondine Biomedical Inc
Ondine Biomedical Inc
Currency: CAD
Millions
TTM
| Mar-2011 | Jun-2011 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue |
0
N/A
|
1
+65%
|
3
+310%
|
1
-67%
|
1
-25%
|
1
+26%
|
1
+50%
|
2
+36%
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
| Gross Profit |
0
N/A
|
0
+43%
|
1
+572%
|
0
-69%
|
0
-27%
|
0
+37%
|
1
+78%
|
1
+40%
|
|
| Operating Income | |||||||||
| Operating Expenses |
(4)
|
(4)
|
(19)
|
(53)
|
(19)
|
(20)
|
(16)
|
(16)
|
|
| Selling, General & Administrative |
(2)
|
(2)
|
(13)
|
(16)
|
(12)
|
(12)
|
(10)
|
(9)
|
|
| Research & Development |
(3)
|
(3)
|
(5)
|
(5)
|
(6)
|
(6)
|
(5)
|
(6)
|
|
| Depreciation & Amortization |
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Other Operating Expenses |
1
|
1
|
0
|
(32)
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(4)
N/A
|
(4)
-6%
|
(18)
-322%
|
(53)
-202%
|
(19)
+65%
|
(20)
-5%
|
(15)
+25%
|
(15)
+1%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
0
|
0
|
(1)
|
(1)
|
1
|
1
|
0
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
(32)
|
0
|
(1)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
1
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(3)
N/A
|
(3)
-9%
|
(50)
-1 456%
|
(54)
-8%
|
(19)
+64%
|
(19)
+3%
|
(14)
+23%
|
(14)
+1%
|
|
| Net Income | |||||||||
| Tax Provision |
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(3)
|
(3)
|
(50)
|
(54)
|
(19)
|
(19)
|
(14)
|
(14)
|
|
| Net Income (Common) |
(3)
N/A
|
(3)
-9%
|
(50)
-1 455%
|
(54)
-8%
|
(19)
+64%
|
(19)
+3%
|
(14)
+23%
|
(14)
+1%
|
|
| EPS (Diluted) |
-0.3
N/A
|
-0.35
-17%
|
-0.63
-80%
|
-0.27
+57%
|
-0.1
+63%
|
-0.1
N/A
|
-0.07
+30%
|
-0.06
+14%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
